Heart health in transgender people on hormone therapy
Part of Heart & circulation, Mental health clinical trials.
This study looks at how gender-affirming hormone therapy affects the heart and blood vessels in transgender people. If you've been on hormones for at least a year, researchers want to check your cardiovascular health to better understand long-term risks and benefits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with gender incongruence
- You are at least 18 years old
- You have been on gender-affirming hormone therapy (testosterone or estradiol with anti-androgens) for at least 12 months
- You did not receive any hormone therapy before this current treatment
- You have never had a heart attack, stroke, or other cardiovascular event before starting hormone therapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how gender-affirming hormone therapy affects the heart and blood vessels. It aims to understand any changes in heart health for transgender individuals starting or continuing this treatment.
This study looks at starting gender-affirming hormone therapy (GAHT) for transgender people who have never had these treatments before. It may help you learn whether this approach is safe and effective for your goals as you begin care.
This study looks at people who are preparing to start gender-affirming hormone treatment. It may help researchers understand what support is needed before hormones begin.
This study looks at the tissue from the uterus and cervix of transgender men who are on testosterone therapy and have gender-affirming surgery to remove those organs. The goal is to understand how long-term testosterone affects these tissues.
This study looks at how gender-affirming hormone therapy affects heart health, metabolism, and mental well-being in transgender adults. It aims to understand the benefits and risks to help improve care.
This study looks at how cross-sex hormone treatment affects the heart and fat in the liver. It aims to help understand the safety of hormone therapy in transgender individuals.
Hear when a new Gender Incongruence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.